Post job

Aerie Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Rajkumar Kannan is the Aerie Pharmaceuticals's CEO. Aerie Pharmaceuticals has 353 employees, of which 46 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Aerie Pharmaceuticals executive team is 24% female and 76% male.
  • 60% of the management team is White.
  • 16% of Aerie Pharmaceuticals management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Aerie Pharmaceuticals?
Share your experience

Rate Aerie Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Rajkumar Kannan

CEO

Casey C. Kopczynski Ph.D.

Chief Innovation Officer

Eric Toone

Founder

Thomas van Haarlem

Founder

John W. Larocca

General Counsel

Michelle Senchyna

VP-Clinical Development & Medical Affairs

Ken Ruettimann

Head of Manufacturing

Peter F. Lang

Chief Financial Officer

Craig R. Skenes

Vice President-Business Development

Gary Jay Sternberg

Chief Medical Officer

Do you work at Aerie Pharmaceuticals?

Does the leadership team provide a clear direction for Aerie Pharmaceuticals?

Aerie Pharmaceuticals jobs

Aerie Pharmaceuticals founders

Name & TitleBio
Casey C. Kopczynski Ph.D.

Chief Innovation Officer

Eric Toone

Founder

Thomas van Haarlem

Founder

Aerie Pharmaceuticals board members

Name & TitleBio
Rajkumar Kannan

CEO

Gerald D. Cagle

Board Member

Gerald D. Cagle, PhD has served as a member of our board of directors since September 2013. Dr. Cagle is currently Chief Operating Officer at Cognoptix, lnc., focused on the diagnosis of Alzheimer’s disease. He also is Senior Advisor and Head of Business Development for GrayBug, LLC, a platform drug delivery company. Previously, Dr. Cagle served as Senior Vice President of Research & Development at Alcon Laboratories lnc. from 1997 to 2008, assuming the responsibility of Chief Scientific Officer in 2006. Dr. Cagle has served on the Wilmer Eye Institute Advisory Council and is a member of the ARVO Foundation Board of Governors. Dr. Cagle received his BS degree from Wayland College and earned both his MS and PhD degrees from the University of North Texas. We believe that Dr. Cagle’s scientific background and experience provides him with the qualifications and skills to serve as a member of our board of directors.

Benjamin F. McGraw

Board Member

David W. Gryska

Board Member

Julie Harris McHugh

Board Member

Peter John McDonnell

Board Member

Richard J. Croarkin

Board Member

Michael M. du Toit

Board Member

Vicente Anido

Board Member

Vicente Anido's LinkedIn

Vicente Anido, Jr., Ph.D. has served as our Chief Executive Officer since July 2013 and as Chairman of our Board since April 2013. Dr. Anido is the former President, Chief Executive Officer, and Director of ISTA Pharmaceuticals, Inc., which was acquired by Bausch + Lomb, Inc. in 2012. Prior to joining ISTA Pharmaceuticals, Dr. Anido served as general partner of Windamere Venture Partners from 2000 to 2001. From 1996 to 1999, Dr. Anido served as President and Chief Executive Officer of CombiChem, Inc., a drug discovery company. From 1993 to 1996, Dr. Anido served as President of the Americas Region of Allergan, Inc., where he was responsible for Allergan’s commercial operations for North and South America. Prior to joining Allergan, Dr. Anido spent 17 years at Marion Laboratories and Marion Merrell Dow, Inc., including as Vice President, Business Management of Marion’s U.S. Prescription Products Division. Dr. Anido previously served as a member of the board of directors of QLT Inc. from 2012 to 2013, Depomed, Inc. from February 2013 to May 2016, and Nicox S.A. from June 2013 to June 2014. In addition, from 2002 to 2008, Dr. Anido served as a member of the board of directors of Apria Healthcare, Inc. Dr. Anido received his B.S. and M.S. from West Virginia University and his Ph.D. from the University of Missouri, Kansas City.

Ann Keevans

Board Member

Aerie Pharmaceuticals leadership demographics

Aerie Pharmaceuticals gender distribution in management team

  • The Aerie Pharmaceuticals executive team is 24% female and 76% male.
  • Aerie Pharmaceuticals is 86% female and 14% male company-wide.
Male
Male
76%
Company-wide: 14%
Female
Female
24%
Company-wide: 86%

Aerie Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Aerie Pharmaceuticals executive officers is White.
  • 60% of the management team is White.
  • 16% of Aerie Pharmaceuticals's management is Hispanic or Latino.
  • 10% of the management team is Asian.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 64% of employees are White.
  • 15% of employees are Hispanic or Latino.
  • 10% of employees are Black or African American.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Aerie Pharmaceuticals jobs nearby

Aerie Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Aerie Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aerie Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Aerie Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aerie Pharmaceuticals. The data presented on this page does not represent the view of Aerie Pharmaceuticals and its employees or that of Zippia.

Aerie Pharmaceuticals may also be known as or be related to AERIE PHARMACEUTICALS INC, Aerie Pharmaceuticals, Aerie Pharmaceuticals Inc, Aerie Pharmaceuticals, Inc. and aerie.